脖围可能提示心血管疾病风险

2015-05-28 佚名 中国循环杂志

脖子粗,肚子大,哪个更能说明心血管风险高?2015美国内分泌外科学会年会上的一项研究认为,对于肥胖者,量脖子比量肚子可更好评估其心血管及代谢疾病的发生风险。        研究者Zdravko Kamenov得意地表示,“颈围更容易测量,并且能较腰围提供更多信息,而且量一下脖子还可提示阻塞性睡眠呼吸暂停。”     

脖子粗,肚子大,哪个更能说明心血管风险高?2015美国内分泌外科学会年会上的一项研究认为,对于肥胖者,量脖子比量肚子可更好评估其心血管及代谢疾病的发生风险。
        
研究者Zdravko Kamenov得意地表示,“颈围更容易测量,并且能较腰围提供更多信息,而且量一下脖子还可提示阻塞性睡眠呼吸暂停。”不过他又认为,目前还不能用颈围取代腰围,但至少颈围可以作为一个补充,以评估心血管及代谢疾病的风险。研究者发现,女性颈围36 cm以上、男性颈围39 cm以上与代谢综合征更相关。
        
该研究共纳入138例体质指数(BMI)不低于30 kg/m2的肥胖患者,其中1/3为男性。41%患有糖尿病,87%有代谢综合征。

实际上,有关脖围与疾病的关系,一直有研究,包括与肿瘤,哮喘,心血管疾病,代谢综合征的风险。甚至有些研究认为,它比BMI,腰围可能更敏感,但是,当前的数据仍然不足。

相关资料:
Han TS, Oh MK, Kim SM, Yang HJ, Lee BS, Park SY, Lee WJ.Relationship between Neck Length, Sleep, and Cardiovascular Risk Factors.Korean J Fam Med. 2015 Jan;36(1):10-21.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=26610, encodeId=a94c26610a7, content=认真学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ac181616815, createdName=ljjj1053, createdTime=Tue Jun 09 17:50:00 CST 2015, time=2015-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=25570, encodeId=d257255e08d, content=看看, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee0d1618732, createdName=huaxipanxing, createdTime=Sun May 31 21:14:00 CST 2015, time=2015-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1472962, encodeId=50c214e2962f7, content=<a href='/topic/show?id=862be0746bc' target=_blank style='color:#2F92EE;'>#疾病风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70746, encryptionId=862be0746bc, topicName=疾病风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3c757221906, createdName=花花1368, createdTime=Sat May 30 05:39:00 CST 2015, time=2015-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1497885, encodeId=408b149e88508, content=<a href='/topic/show?id=bb6f89e145a' target=_blank style='color:#2F92EE;'>#血管疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89714, encryptionId=bb6f89e145a, topicName=血管疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ccb99370406, createdName=andy2090, createdTime=Sat May 30 05:39:00 CST 2015, time=2015-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=25293, encodeId=13482529348, content=可参考, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=MedSci客户端网友, createdTime=Fri May 29 15:10:00 CST 2015, time=2015-05-29, status=1, ipAttribution=)]
    2015-06-09 ljjj1053

    认真学习了

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=26610, encodeId=a94c26610a7, content=认真学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ac181616815, createdName=ljjj1053, createdTime=Tue Jun 09 17:50:00 CST 2015, time=2015-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=25570, encodeId=d257255e08d, content=看看, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee0d1618732, createdName=huaxipanxing, createdTime=Sun May 31 21:14:00 CST 2015, time=2015-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1472962, encodeId=50c214e2962f7, content=<a href='/topic/show?id=862be0746bc' target=_blank style='color:#2F92EE;'>#疾病风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70746, encryptionId=862be0746bc, topicName=疾病风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3c757221906, createdName=花花1368, createdTime=Sat May 30 05:39:00 CST 2015, time=2015-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1497885, encodeId=408b149e88508, content=<a href='/topic/show?id=bb6f89e145a' target=_blank style='color:#2F92EE;'>#血管疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89714, encryptionId=bb6f89e145a, topicName=血管疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ccb99370406, createdName=andy2090, createdTime=Sat May 30 05:39:00 CST 2015, time=2015-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=25293, encodeId=13482529348, content=可参考, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=MedSci客户端网友, createdTime=Fri May 29 15:10:00 CST 2015, time=2015-05-29, status=1, ipAttribution=)]
    2015-05-31 huaxipanxing

    看看

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=26610, encodeId=a94c26610a7, content=认真学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ac181616815, createdName=ljjj1053, createdTime=Tue Jun 09 17:50:00 CST 2015, time=2015-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=25570, encodeId=d257255e08d, content=看看, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee0d1618732, createdName=huaxipanxing, createdTime=Sun May 31 21:14:00 CST 2015, time=2015-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1472962, encodeId=50c214e2962f7, content=<a href='/topic/show?id=862be0746bc' target=_blank style='color:#2F92EE;'>#疾病风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70746, encryptionId=862be0746bc, topicName=疾病风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3c757221906, createdName=花花1368, createdTime=Sat May 30 05:39:00 CST 2015, time=2015-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1497885, encodeId=408b149e88508, content=<a href='/topic/show?id=bb6f89e145a' target=_blank style='color:#2F92EE;'>#血管疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89714, encryptionId=bb6f89e145a, topicName=血管疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ccb99370406, createdName=andy2090, createdTime=Sat May 30 05:39:00 CST 2015, time=2015-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=25293, encodeId=13482529348, content=可参考, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=MedSci客户端网友, createdTime=Fri May 29 15:10:00 CST 2015, time=2015-05-29, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=26610, encodeId=a94c26610a7, content=认真学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ac181616815, createdName=ljjj1053, createdTime=Tue Jun 09 17:50:00 CST 2015, time=2015-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=25570, encodeId=d257255e08d, content=看看, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee0d1618732, createdName=huaxipanxing, createdTime=Sun May 31 21:14:00 CST 2015, time=2015-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1472962, encodeId=50c214e2962f7, content=<a href='/topic/show?id=862be0746bc' target=_blank style='color:#2F92EE;'>#疾病风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70746, encryptionId=862be0746bc, topicName=疾病风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3c757221906, createdName=花花1368, createdTime=Sat May 30 05:39:00 CST 2015, time=2015-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1497885, encodeId=408b149e88508, content=<a href='/topic/show?id=bb6f89e145a' target=_blank style='color:#2F92EE;'>#血管疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89714, encryptionId=bb6f89e145a, topicName=血管疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ccb99370406, createdName=andy2090, createdTime=Sat May 30 05:39:00 CST 2015, time=2015-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=25293, encodeId=13482529348, content=可参考, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=MedSci客户端网友, createdTime=Fri May 29 15:10:00 CST 2015, time=2015-05-29, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=26610, encodeId=a94c26610a7, content=认真学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ac181616815, createdName=ljjj1053, createdTime=Tue Jun 09 17:50:00 CST 2015, time=2015-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=25570, encodeId=d257255e08d, content=看看, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee0d1618732, createdName=huaxipanxing, createdTime=Sun May 31 21:14:00 CST 2015, time=2015-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1472962, encodeId=50c214e2962f7, content=<a href='/topic/show?id=862be0746bc' target=_blank style='color:#2F92EE;'>#疾病风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70746, encryptionId=862be0746bc, topicName=疾病风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3c757221906, createdName=花花1368, createdTime=Sat May 30 05:39:00 CST 2015, time=2015-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1497885, encodeId=408b149e88508, content=<a href='/topic/show?id=bb6f89e145a' target=_blank style='color:#2F92EE;'>#血管疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89714, encryptionId=bb6f89e145a, topicName=血管疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ccb99370406, createdName=andy2090, createdTime=Sat May 30 05:39:00 CST 2015, time=2015-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=25293, encodeId=13482529348, content=可参考, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=MedSci客户端网友, createdTime=Fri May 29 15:10:00 CST 2015, time=2015-05-29, status=1, ipAttribution=)]
    2015-05-29 MedSci客户端网友

    可参考

    0

相关资讯

JAMA Intern Med:霍奇金淋巴瘤治疗增加了填远期心血管疾病风险

    霍奇金淋巴瘤(HL)幸存者正处于心血管疾病的危险性增加时期。但是目前还不清楚的是多长时间增加的风险仍然存在,以及什么各种心血管疾病的风险因素。    为了检验在一般人群中HL与心血管疾病的发病率相比较,长达40年的相对和绝对过量风险,并研究不同心血管疾病相关的危险因素。    本回顾性队列研究纳入2524例诊断为HL的荷兰患者,年

严肃话题:“高”OR“矮”,哪个更健康?

我们都有过这样的经历:“快看,那个人好高!”“哎呀,我比你高,嘿嘿”—“你懂啥,浓缩的就是精华!”“长那么高容易驼背知道不?”—“但是走路比你快呀,而且上面的空气好!”那么,问题来了,究竟是长得高好还是长得矮好?一.长得矮点好1、PLoS ONE:科学家发现身材矮小的男性寿命更长(查看原文)2014年5月7日刊登在国际杂志PLoS One上的一篇研究论文中,来自夏威夷大学的研究人员通过

Circulation:父母吸烟会给孩子带来长期心血管疾病风险

长期暴露于父母吸烟环境下的儿童可能比那些父母不吸烟的儿童在成年后遭受更高的心脏疾病风险。这项研究的结果最近发布于美国心脏协会杂志Circulation上。该研究结果更加促进了关于暴露在父母吸烟环境下对儿童心血管健康问题会造成长期的影响方面的证据。 研究人员跟踪了一项名为Cardiovascular Risk in Young Finns Study的调查研究,该研究包含了1980~1983年

JCO:前列腺癌患者的心血管疾病的发病风险和时间

目的:明确前列腺癌患者接受不同类型的去势治疗与发生心血管疾病的风险和发生心血管疾病的时间这三者之间的联系。 方法:利用在瑞典国家卫生保健登记处的药品处方数据,采用多变量COX比例风险回归模型,通过与187785名未患前列腺癌的、年纪相当的正常人相对照,调查了41362名接受去势治疗的前列腺癌患者的心血管疾病的患病风险。 结果:2006至2012年期间,10656名患者接受抗雄激素治疗,2695

Obesity:怀孕让肥胖女性更健康

众所周知,超重/肥胖人群的心血管疾病罹患风险会增加,但是这群人中,对于育龄期女性,怀孕这个特殊神圣的过程能否让其风险发生改变呢?Niemczyk NA等人在超重/肥胖的育龄期女性中进行了一项研究,以探究亚临床心血管疾病(CVD)与产次的关系。

胡大一:关爱糖尿病患者——从“心”开始

糖尿病与心血管疾病(CVD)关系密切,充分认识糖代谢异常与心血管病之间的密切关系,对于心血管疾病多重危险因素的综合防治具有重要意义。Framingham研究30余年随访结果证实,与非糖尿病者相比,糖尿病患者的冠心病、卒中、心力衰竭危险增加2~10倍。中美队列随访至1997年的分析结果显示,糖尿病是中国中年人群冠心病和卒中的独立危险因素,仅次于高血压。中国心血管报告2007提示,中国糖尿病患者缺血性